Loading
Loading
Sarepta Therapeutics ceo salary
Douglas S. Ingram, Chief Executive Officer of Sarepta Therapeutics, Inc. (SRPT), received $7,840,666 ($7.8M) in total compensation for FY2025, up 296.4% from the prior year. Stock awards of $6,000,005 were the largest component. Figures come from Sarepta Therapeutics, Inc.'s DEF 14A filed 24 Apr 2026 (accession 0001193125-26-177247).
Reported total from the latest DEF 14A pay table. Source filing (accession 0001193125-26-177247). These figures come from Sarepta Therapeutics, Inc.'s DEF 14A filed 24 Apr 2026 (accession 0001193125-26-177247).
| Component | Amount |
|---|---|
| Salary | $1,171,425 |
| Stock awards | $6,000,005 |
| Cash incentive | $649,000 |
| Other | $20,236 |
| Total | $7,840,666 |
FAQ
See also: SRPT ticker page